Global Needles Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Get Exclusive Sample PDF of this Report Here

Needles Market Analysis

• Needles are critical components in medical care, used for injecting medications, drawing blood, and performing a wide range of diagnostic and therapeutic procedures with accuracy and safety. They are integral across various settings including hospitals, clinics, and home healthcare, supporting effective drug delivery and patient monitoring
• The needles market is experiencing steady growth fueled by the rising prevalence of chronic diseases, increasing demand for self-administration devices, expansion of vaccination programs, technological advancements in needle design, and a growing number of surgical and diagnostic procedures
• North America is expected to dominate the needles market with a share of 43%, due to a well-established healthcare infrastructure, strong investment in advanced medical devices, and high demand for injectable drugs and self-administration devices
• Asia-Pacific is expected to be the fastest growing region in the needles market during the forecast period due to increasing government initiatives to promote awareness, a rise in medical tourism, and the growing demand for quality healthcare
• Conventional needles segment is expected to dominate the market with a market share of 72.3% due to their widespread adoption in routine medical procedures, lower cost compared to safety needles, and ease of manufacturing and availability, particularly in emerging markets where budget constraints and limited access to advanced safety technologies prevail

Report Scope and Needles Market Segmentation     

Get Exclusive Sample PDF of this Report Here

Needles Market Trends

“Growing Adoption of Safety-Engineered Needles”

• One prominent trend in the global needles market is the growing adoption of safety-engineered needles
• This trend is driven by the increasing awareness of needlestick injuries, rising regulatory pressure to improve occupational safety, and the need to reduce healthcare-associated risks

• For instance, healthcare facilities are increasingly shifting to safety needles, prompting companies such as BD and Medline to expand their portfolios with retractable and shielded needle technologies

• The demand for safety-engineered designs is also growing across hospitals, clinics, and home care settings due to their role in preventing accidental exposures
• As healthcare systems continue prioritizing staff safety and compliance, this trend is expected to significantly influence innovation and investment in the needles market

Needles Market Dynamics

Driver

“Rising Prevalence of Chronic Diseases”

• The rising prevalence of chronic diseases is a major driver of growth in the needles market, as conditions such as diabetes, cancer, and cardiovascular disorders require frequent injections, blood sampling, and drug administration
• This demand is especially evident in long-term management of diseases such as diabetes, where patients rely on insulin delivery through pen needles and hypodermic needles
• As chronic disease rates climb globally, particularly in aging populations, there is increased need for reliable, easy-to-use needle solutions across hospitals, clinics, and home healthcare settings
• Manufacturers are responding by developing advanced needle designs that minimize pain, improve safety, and support self-administration, especially for chronic care patients
• The focus on disease prevention, early diagnosis, and long-term treatment is accelerating needle consumption in both developed and emerging markets

For instance,

• BD has expanded its pen needle offerings with ultra-fine technologies that cater to diabetic patients requiring daily injections
• Nipro and Terumo are investing in product innovations to meet rising global demand for chronic disease-related injection therapies

• As the burden of chronic diseases continues to grow, this driver is expected to play a central role in shaping product development and market expansion in the global needles market

Opportunity

“Growing Demand for Injectable Drugs”

• The growing demand for injectable drugs presents a significant opportunity for the needles market, driven by the increasing reliance on injectable therapies for conditions such as diabetes, cancer, and autoimmune disorders
• Healthcare providers and pharmaceutical companies are seeking advanced needle solutions that ensure precise drug delivery, minimize discomfort, and support patient adherence to treatment regimens
• This opportunity aligns with the global rise in injectable drug volumes, where needles play a critical role in providing efficient, accurate administration of biologics, vaccines, and insulin therapies

For instance,

• Companies such as Mylan are expanding their needle offerings to support the delivery of injectable biosimilars, addressing the increasing demand for cost-effective biologics
• Becton Dickinson (BD) has developed a line of smart safety needles designed to enhance user safety and ease of use, catering to the growing focus on reducing injection-related injuries

• As the demand for injectable drugs continues to rise globally, the needles market is well-positioned to capitalize on this expanding segment by offering innovative, patient-centric solutions

Restraint/Challenge

“Stringent Regulatory Requirements and Quality Standards”

• Stringent regulatory requirements and quality standards pose a significant challenge for the needles market, as manufacturers must adhere to strict guidelines to ensure product safety and efficacy
• The need to comply with varying regulations across regions, such as the U.S. FDA's approval processes and the European Union's CE marking requirements, increases the complexity and cost of product development and manufacturing
• This challenge is particularly pronounced in emerging markets, where local regulatory bodies may have less established frameworks, leading to delays in market entry and higher compliance costs for global manufacturers

For instance,

• Leading companies such as BD and Terumo are investing heavily in regulatory affairs and quality assurance teams to navigate global standards, but many smaller manufacturers face difficulties in meeting these stringent requirements

• The complexity of regulatory compliance may slow product innovation and hinder market expansion, especially in regions with less robust regulatory infrastructures, limiting the accessibility of advanced needle technologies in these markets

Needles Market Scope

The market is segmented on the basis of type, product, delivery mode, material, distribution channel, and end user.

Get Exclusive Sample PDF of this Report Here

In 2025, the conventional needles is projected to dominate the market with a largest share in type segment

The conventional needles segment is expected to dominate the needles market with the largest share of 72.3% in 2025 due to their widespread adoption in routine medical procedures, lower cost compared to safety needles, and ease of manufacturing and availability, particularly in emerging markets where budget constraints and limited access to advanced safety technologies prevail.

The pen needles is expected to account for the largest share during the forecast period in product segment

In 2025, the pen needles segment is expected to dominate the market due to rising global prevalence of diabetes, increasing demand for self-administration of insulin, and the growing adoption of user-friendly, minimally invasive delivery systems that enhance patient compliance and convenience.

Needles Market Regional Analysis

“North America Holds the Largest Share in the Needles Market”

• North America dominates the needles market with a share of 43%, driven by a well-established healthcare infrastructure, strong investment in advanced medical devices, and high demand for injectable drugs and self-administration devices
• U.S. holds a significant share due to its extensive healthcare infrastructure, high adoption of safety-engineered needles, and continued investments in drug delivery technologies, especially for chronic disease management and self-administration of injectables
• The region's dominance is further supported by the presence of major market players such as BD and Medtronic, high healthcare spending, and a favorable regulatory environment, which encourage the development and use of innovative needle products
• In addition, the growing demand for advanced safety needles and a high number of medical research activities are expected to sustain North America’s leadership in the needles market through 2032

“Asia-Pacific is Projected to Register the Highest CAGR in the Needles Market”

• Asia-Pacific is expected to witness the highest growth rate in the needles market, driven by increasing government initiatives to promote awareness, a rise in medical tourism, and the growing demand for quality healthcare
• China holds a significant share due to its expanding healthcare infrastructure, large population, and rising demand for injectable drugs and self-administered therapies, as well as government-backed initiatives to improve healthcare access
• The region’s rapid market expansion is supported by favorable government policies, the increasing availability of advanced medical devices, and a growing patient pool requiring injectable therapies and surgical procedures
• As awareness grows and healthcare infrastructure improves, Asia-Pacific is expected to be a key growth engine in the global needles market through 2032

Needles Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Medtronic (Ireland)
• Thermo Fisher Scientific Inc. (U.S.)
• Novo Nordisk A/S (Denmark)
• BD (U.S.)
• Stryker (U.S.)
• Boston Scientific Corporation (U.S.)
• Luminex Corporation ((U.S.)
• Illumina, Inc (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• QIAGEN (Netherlands)
• Abcam plc (U.K.)
• Merck KGaA (Germany)
• Promega Corporation (U.S.)
• Siemens (Germany)
• PerkinElmer, Inc. (U.S.)
• Shimadzu Corporation (Japan)

Latest Developments in Global Needles Market

• In March 2024, Hindustan Syringes and Medical Devices (HMD) launched Dispojekt single-use syringes with safety needles, aimed at reducing Needle Stick Injuries (NSIs) among healthcare workers. These syringes are expected to lower infection control costs, disposal expenses, and training needs, providing long-term financial benefits to the healthcare sector. With domestically manufactured, advanced technology, HMD is positioning India to compete globally in the sharp injury prevention syringe market, strengthening its market presence both locally and internationally
• In November 2023, Terumo India, the Indian arm of global medical technology leader Terumo Corporation, announced the launch of its Insulin Syringe, a sterile delivery device designed for patients requiring regular insulin injections. This new product aims to enhance patient comfort and improve therapy compliance, setting a higher standard for diabetes care
• In September 2022, Terumo India, the Indian arm of global medical technology leader Terumo Corporation, launched the FineGlide Sterile Pen Needle for patients requiring regular insulin injections or other self-medication. Compatible with most commonly available pen devices in India, FineGlide is designed to enhance patient comfort, ultimately improving drug compliance. This launch aims to raise the standard of care for individuals managing chronic conditions in India
• In May 2022, Roche Diabetes Care India (RDC India) introduced Accu-Fine, a line of high-quality pen needles designed to enhance the insulin delivery experience for individuals with diabetes. This new offering from Roche Diabetes Care, known for its Accu-Chek brand, is aimed at improving the ease of insulin delivery, ultimately supporting better diabetes management for patients

SKU-8746